genOway

📍 Lyon, France🗓 Founded 1999👥 102 employees💰 Last funded Mar 2012
Biotechnology Research🌐 genoway.com
Website LinkedIn
Founded in 1999, genOway is a global biotechnology company dedicated to the development and commercialization of unique, innovative genetically modified mouse, rat and cell line models for fundamental, preclinical and clinical research. Based on its core business and leading expertise in custom-designed models, the company invests in cancer research, with a growing catalog of currently over 30 translational models for immuno-oncology and immunotherapy. genOway holds all relevant licenses on patented technologies used for its model creation, including the exclusive license under Merck’s foundational CRISPR/Cas9 patents portfolio, which enables the company to guarantee its clients FTO, freedom to operate. Headquartered in Lyon, France, genOway serves clients in 380 academic institutions and 170 life sciences companies, including 17 of the top 20 pharma.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
1999
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
France
1
Frequently asked questions
Who invested in genOway?
genOway has 1 investors on record on gritt.io.
When did genOway last raise funding?
The most recent investment in genOway recorded on gritt.io was in March 2012.
When was genOway founded?
genOway was founded in 1999.
What industry is genOway in?
genOway operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is genOway based?
genOway is headquartered in Lyon, France.